Blog


Endo International Settles Securities Settlement for $82.5 Million

Second Endo Settlement of 2019



Endo International... Sound familiar? Earlier this August we posted a blog with a similar title “Endo International Settles Securities Settlement for $50 Million.”

So what’s the difference? Aside from $32.5 million.

The first settlement pertained to declining demand for Endo’s generic drugs and also alleged that Endo had conspired to fix prices, which resulted in inflated stock and later a law enforcement inquiry. Once the scheme collapsed, plaintiffs alleged, the stock price collapsed with it.

This newer settlement pertains to Endo’s role in the opioid crisis. Specifically, plaintiffs allege that “failed to disclose material adverse facts regarding the putative safety and abuse-deterrent properties of Reformulated Opana, an opioid analgesic indicated for the management of severe pain that requires daily opioid treatment.”

Here are the other key facts:

Case name: Endo International

Settlement fund: $82,500,000

Claim filing deadline: 2/7/2020

Class period: 11/30/2012 – 6/8/2017

Definition of class from settlement notice:

“All persons and entities who purchased or otherwise acquired Endo common stock or ordinary shares between November 30, 2012 and June 8, 2017, inclusive, and were damaged thereby.”

Fairness Hearing: 12/11/2019

Exclusion Deadline: 11/22/2019

Objection Deadline: 11/22/2019

How Chicago Clearing Can Help: Every day, our team files claims in a wide assortment of financial class action litigations. We are preparing claims now for potential Endo International Class members… in both settlements! If you or your clients are eligible for this litigation, or any of the other 35 settlements with upcoming deadlines, then please give us a call at 312-204-6970.


More News from the Class Action World



NERA Economic Consulting has released Read More

Two bits of news about the $386.5 Million GSE Bonds Litigation: first, the claim filing deadline has been extended to February 28, 2020. (The objection deadline has likewise been extended to February 14.) Consider... Read More


In a recent post, we discussed the first two settlements in the GSE Bonds Antitrust litigation which then totaled $49.5 million. (Well, $29.5 Million was the initial settlement amount, as... Read More

Good news for those investors who purchased Valeant securities between January 4, 2013 and March 15, 2016. Plaintiffs and Valeant (now known as Bausch Health) have hammered out a $1.21 billion settlement. Settlement notices and claim forms are not yet available, but Chicago Clearing Corporation (CCC) will begin preparing claims for o... Read More

Did you trade debt securities of government sponsored enterprises (aka GSE bonds) between 2009 and 2019? If so, you may be eligible to participate in an antitrust settlement.

Plaintiffs allege that the defendants (see full list below) conspired to fix prices of unsecured GSE bonds issued by Federal ... Read More

Case Name: Akorn 2019 Securities Settlement

Settlement Fund: Between $53.6 million and $155.4 Million

Claim Filing Deadline: January 24, 2020

Class Period: 11/3/2016 – 1/8/2019

Read More